DSKX Insider Trading Activity and SEC Form 4 Filings
DSKX insider trading summary
No open-market insider purchases or sales of Ds Healthcare Group, Inc. (DSKX) have been reported on SEC Form 4 in the past 12 months.
Latest DSKX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 17, 2017 | Yasuhiro Fujiwara | Chief Executive Officer | Buy | $250K (2,500,000 @ $0.10) |
| Nov 8, 2015 | Daniel Khesin | CEO and CFO | Sell | $42.35B (175,000 @ $242000.00) |
| Jun 25, 2015 | Daniel Khesin | CEO and CFO | Buy | $10K (3,000 @ $3.25) |
| Jun 23, 2015 | Daniel Khesin | CEO and CFO | Buy | $10K (2,225 @ $4.51) |
| Jun 18, 2015 | Mark Edward Wolfson | Director | Sell | $118K (27,650 @ $4.28) |
| Jun 15, 2015 | Daniel Khesin | CEO and CFO | Buy | $13K (3,500 @ $3.71) |
| May 21, 2015 | Daniel Khesin | CEO and CFO | Buy | $2K (1,000 @ $2.07) |
| Nov 17, 2014 | Daniel Khesin | CEO and CFO | Buy | $800 (1,000 @ $0.80) |
| Nov 7, 2014 | Daniel Khesin | CEO and CFO | Buy | $850 (1,000 @ $0.85) |
| Sep 10, 2014 | Mark Edward Wolfson | Director | Buy | $3K (2,389 @ $1.09) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.